Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Hollingsworth EB and Patrick GA | Involvement of the serotonergic system in the prolongation of pentobarbital sleeping time produced by prostaglandin D2. | 1985 | Pharmacol. Biochem. Behav. | pmid:2859604 |
Csányi G et al. | Effects of 3-aminopyridine-induced seizures on platelet eicosanoid synthesis. | 2008 May-Jun | Pharmacol Rep | pmid:18622059 |
Bhattacharya SK and Parmar SS | Prostaglandin D2 inhibits pentylenetetrazole-induced convulsions in rats by a serotonin-mediated mechanism. | 1987 | Pharm. Res. | pmid:2977646 |
Hagens WI et al. | Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. | 2007 | Pharm. Res. | pmid:17245650 |
Eichele K et al. | R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway. | 2009 | Pharm. Res. | pmid:19015962 |
Peeraully MR et al. | Prostaglandin D2 and J2-series (PGJ2, Delta12-PGJ2) prostaglandins stimulate IL-6 and MCP-1, but inhibit leptin, expression and secretion by 3T3-L1 adipocytes. | 2006 | Pflugers Arch. | pmid:16924534 |
Zhao H et al. | Met-Arg-Trp derived from Rubisco lowers blood pressure via prostaglandin D(2)-dependent vasorelaxation in spontaneously hypertensive rats. | 2008 | Peptides | pmid:18180074 |
Bai G et al. | Regulation of ANP secretion from isolated atria by prostaglandins and cyclooxygenase-2. | 2009 | Peptides | pmid:19539681 |
Zhao H et al. | Rubimetide (Met-Arg-Trp) derived from Rubisco exhibits anxiolytic-like activity via the DP1 receptor in male ddY mice. | 2008 | Peptides | pmid:18243414 |
Shimatsu A et al. | Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood. | 1984 Mar-Apr | Peptides | pmid:6591147 |
Wang Y et al. | Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. | 2009 | Pediatr. Res. | pmid:19262292 |
Uemura S et al. | Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart. | 1984 | Pediatr. Res. | pmid:6596550 |
Masamune A et al. | Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. | 2002 | Pancreas | pmid:11854617 |
Hashimoto K et al. | Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. | 2004 | Pancreas | pmid:15028947 |
Hashimoto K et al. | The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis. | 2003 | Pancreas | pmid:12826907 |
Closa D et al. | Prostaglandin D2, F2 alpha, E2, and E1 in early phase of experimental acute necrohemorrhagic pancreatitis in rats. | 1994 | Pancreas | pmid:7509066 |
Ebersberger A et al. | Effects of prostaglandin D2 on tetrodotoxin-resistant Na+ currents in DRG neurons of adult rat. | 2011 | Pain | pmid:21345590 |
Minami T et al. | Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice. | 1994 | Pain | pmid:7916452 |
Fahmi H et al. | Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1. | 2002 | Osteoarthr. Cartil. | pmid:11869069 |
Fahmi H et al. | 15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes. | 2002 | Osteoarthr. Cartil. | pmid:12435328 |
Blázovics A et al. | [Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases]. | 2004 | Orv Hetil | pmid:15662752 |
Sheddan NA and Mulzer J | Cross metathesis as a general strategy for the synthesis of prostacyclin and prostaglandin analogues. | 2006 | Org. Lett. | pmid:16805562 |
Brummond KM et al. | The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry. | 2004 | Org. Lett. | pmid:14723515 |
Huisingh C and McGwin G | Change in prostaglandin expression levels and synthesizing activities. | 2013 | Ophthalmology | pmid:24001535 |
Rim TH et al. | Author reply: To PMID 22858125. | 2013 | Ophthalmology | pmid:24001536 |
Shim J et al. | Change in prostaglandin expression levels and synthesizing activities in dry eye disease. | 2012 | Ophthalmology | pmid:22858125 |
Ogino N et al. | Phagocytic activity of cultured retinal pigment epithelial cells from chick embryo: inhibition by melatonin and cyclic AMP, and its reversal by taurine and cyclic GMP. | 1983 | Ophthalmic Res. | pmid:6136017 |
Woodward DF et al. | Marked differential effects of prostanoid metabolites on rabbit intraocular pressure. | 1989 | Ophthalmic Res. | pmid:2626239 |
Walther U et al. | Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway. | 2016 | Oncotarget | pmid:26863638 |
Yen CC et al. | Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. | 2014 | Oncotarget | pmid:24566468 |
Yuan J et al. | M2 microglia promotes neurogenesis and oligodendrogenesis from neural stem/progenitor cells via the PPARγ signaling pathway. | 2017 | Oncotarget | pmid:28423639 |
Servidei T et al. | The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. | 2004 | Oncol. Res. | pmid:15301425 |
Crabb SJ et al. | BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells. | 2008 | Oncol. Rep. | pmid:18288403 |
Takashima T et al. | Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. | 2005 | Oncol. Rep. | pmid:15756430 |
Burgermeister E et al. | Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. | 2003 | Oncogene | pmid:12813462 |
Kar R et al. | A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. | 2009 | Oncogene | pmid:19448671 |
Kim DH et al. | 15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue. | 2010 | Oncogene | pmid:20208557 |
Menon R et al. | Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor. | 2011 | Obstet Gynecol | pmid:21691170 |
Norwitz ER et al. | Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry. | 1992 | Obstet Gynecol | pmid:1495703 |
Schäffler A et al. | Regulation and function of collagenous repeat containing sequence of 26-kDa protein gene product "cartonectin". | 2007 | Obesity (Silver Spring) | pmid:17299102 |
Juman S et al. | Effects of long-term oral administration of arachidonic acid and docosahexaenoic acid on the immune functions of young rats. | 2013 | Nutrients | pmid:23760060 |
Fajas L et al. | PPAR gamma: an essential role in metabolic control. | 2001 | Nutr Metab Cardiovasc Dis | pmid:11383325 |
Corren J et al. | Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial. | 2008 | Nutr J | pmid:18625073 |
Marone G et al. | The human heart as a shock organ in anaphylaxis. | 2004 | Novartis Found. Symp. | pmid:15025396 |
Nakamura O et al. | [Antineoplastic effect of prostaglandins on human glioma in athymic nude mice]. | 1988 | No To Shinkei | pmid:3179087 |
Urade Y and Eguchi N | [Sleep substances]. | 2003 | No To Shinkei | pmid:12649899 |
Takeshima Y | [Development of novel therapeutic approaches for Duchenne muscular dystrophy]. | 2014 | No To Hattatsu | pmid:24738186 |
Urade Y and Mohri I | [Sleep and brain function]. | 2006 | No To Hattatsu | pmid:16986732 |
González E et al. | Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. | 2002 | Nitric Oxide | pmid:11890746 |
Onoe H | [Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2]. | 1998 | Nippon Yakurigaku Zasshi | pmid:10202759 |